{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:05:54Z","timestamp":1790809554235,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jad.2020.11.123","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T19:58:04Z","timestamp":1606766284000},"page":"82-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review"],"prefix":"10.1016","volume":"281","author":[{"given":"Jolien K.E.","family":"Veraart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne Y.","family":"Smith-Apeldoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm-Pieter","family":"Spaans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schoevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.11.123_bib0001","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2015.06.033","article-title":"Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT","volume":"186","author":"Allen","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.11.123_bib0002","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.4088\/JCP.17f11567","article-title":"Ketamine for depression, 1: clinical summary of issues related to efficacy, adverse effects, and mechanism of action","volume":"78","author":"Andrade","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jad.2020.11.123_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2020.01.002","article-title":"Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients","volume":"123","author":"Basso","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2020.11.123_bib0004","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/02791072.2015.1072653","article-title":"Long-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine\u2019s antidepressant response and the development of ketamine addiction","volume":"47","author":"Bonnet","year":"2015","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jad.2020.11.123_bib0005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.psychres.2014.08.023","article-title":"Comparison of ketamine vs. ECT in major depressive disorder: need for ECT standard dosing and duration parameters","volume":"225","author":"Campion","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.11.123_bib0006","first-page":"1","article-title":"What urologists need to know about ketamine-induced uropathy: a systematic review","author":"Castellani","year":"2020","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.jad.2020.11.123_bib0007","series-title":"Ketamine for Treatment-Resistant Depression: the First Decade of Progress","first-page":"13","article-title":"The basic and clinical pharmacology of ketamine,","author":"Fourcade","year":"2016"},{"key":"10.1016\/j.jad.2020.11.123_bib0008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3949\/ccjm.75.1.57","article-title":"The STAR*D study: treating depression in the real world","volume":"75","author":"Gaynes","year":"2008","journal-title":"Cleve Clin. J. Med."},{"key":"10.1016\/j.jad.2020.11.123_bib0009","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.psychres.2013.12.008","article-title":"Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder","volume":"215","author":"Ghasemi","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.11.123_bib0010","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.2147\/NDT.S117146","article-title":"Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies","volume":"12","author":"Han","year":"2016","journal-title":"Neuropsych. dis treat"},{"key":"10.1016\/j.jad.2020.11.123_bib0011","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4088\/JCP.14r09528","article-title":"Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors","volume":"76","author":"Haq","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.11.123_bib0012","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00406-013-0420-5","article-title":"Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study","volume":"264","author":"Hoyer","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2020.11.123_bib0013","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1192\/bjp.bp.109.066183","article-title":"Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial","volume":"196","author":"Kellner","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.11.123_bib0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.psychres.2014.08.021","article-title":"Speed of response to electroconvulsive therapy compared with ketamine","volume":"225","author":"Kellner","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.11.123_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/abr.abr_166_18","article-title":"Comparative effect of intravenous ketamine and electroconvulsive therapy in major depression: a randomized controlled trial","volume":"8","author":"Kheirabadi","year":"2019","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.jad.2020.11.123_bib0016","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2020.11.123_bib0017","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/hbm.24895","article-title":"Modulation of amygdala reactivity following rapidly acting interventions for major depression","volume":"41","author":"Loureiro","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jad.2020.11.123_bib0018","doi-asserted-by":"crossref","first-page":"19\u201026","DOI":"10.1016\/j.cct.2018.12.009","article-title":"ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with treatment-resistant depression: the ELEKT-D study protocol","volume":"77","author":"Mathew","year":"2019","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.jad.2020.11.123_bib0019","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Internal Med."},{"key":"10.1016\/j.jad.2020.11.123_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fpsyt.2014.00149","article-title":"Long-term heavy ketamine use is associated with spatial memory impairment and altered hippocampal activation","volume":"5","author":"Morgan","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2020.11.123_bib0021","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1176\/appi.ps.201300059","article-title":"A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013","volume":"65","author":"Mrazek","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2020.11.123_bib0022","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2006.05.008","article-title":"The burden of severe depression: a review of diagnostic challenges and treatment alternatives","volume":"41","author":"Nemeroff","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2020.11.123_bib0023","first-page":"81","article-title":"Maintaining rapid antidepressant effects following ketamine infusion: a major unmet need","author":"Papakostas","year":"2020","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.jad.2020.11.123_bib0024","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12888-020-02672-3","article-title":"A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol","volume":"20","author":"Phillips","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2020.11.123_bib0025","first-page":"13","article-title":"Pharmacological treatments for patients with treatment-resistant depression","author":"Ruberto","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jad.2020.11.123_bib0026","first-page":"779","article-title":"Modern electroconvulsive therapy: vastly improved yet greatly underused","volume":"74","author":"Sackeim","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2020.11.123_bib0027","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.285.10.1299","article-title":"Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial","volume":"285","author":"Sackeim","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jad.2020.11.123_bib0028","first-page":"A2","article-title":"Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy","volume":"1","author":"Sackeim","year":"2008","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2020.11.123_bib0029","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jad.2020.07.066","article-title":"Antidepressant effects of ketamine and ECT: a pilot comparison","volume":"276","author":"Sharma","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.11.123_bib0031","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2020.11.123_bib0032","first-page":"355","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.11.123_bib0033","first-page":"366","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.11.123_bib0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1192\/bjp.2017.28","article-title":"Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis","volume":"212","author":"van Diermen","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.11.123_bib0035","unstructured":"Veraart, J.K.E., Smith-Apeldoorn, S.Y., Spijker, J., Schoevers, R.A. Ketamine treatment and risk of psychosis in vulnerable patients: a systematic review; submitted for publication.2021."},{"key":"10.1016\/j.jad.2020.11.123_bib0036","first-page":"632","article-title":"[Doctor, will I get my memory back? Electroconvulsive therapy and cognitive side-effects in daily practice]","volume":"59","author":"Verwijk","year":"2017","journal-title":"Tijdschr. Psychiatr."},{"key":"10.1016\/j.jad.2020.11.123_bib0037","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ajp.2012.12.010","article-title":"Battery for ECT related cognitive deficits (B4ECT-ReCoDe): development and validation","volume":"6","author":"Viswanath","year":"2013","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jad.2020.11.123_bib0038","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4088\/JCP.19m12891","article-title":"Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)","volume":"81","author":"Wajs","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.11.123_bib0039","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1176\/appi.ps.201700364","article-title":"Identifying recipients of electroconvulsive therapy: data from privately insured Americans","volume":"69","author":"Wilkinson","year":"2018","journal-title":"Psychiatr Serv."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720330573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720330573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:47:45Z","timestamp":1759024065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720330573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":38,"alternative-id":["S0165032720330573"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.11.123","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.11.123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}